ArticleInternational journal of biological macromolecules2023

Cetuximab-based PROteolysis targeting chimera for effectual downregulation of NSCLC with varied EGFR mutations.

Richa Vartak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.